<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00237692</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 04-426</org_study_id>
    <nct_id>NCT00237692</nct_id>
  </id_info>
  <brief_title>Hypertension Intervention Nurse Telemedicine Study (HINTS)</brief_title>
  <official_title>Behavioral/Pharmacological Telemedicine Interventions for BP Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are 65 million Americans and over 8.5 million veterans who have been diagnosed with
      hypertension; yet only 31% of all hypertensive patients have their blood pressure (BP) under
      effective control (less than 140/90 mm/Hg). Uncontrolled hypertension greatly increases the
      risk of cerebral vascular accidents, coronary artery disease, myocardial infarction, renal
      failure, congestive heart failure, and mortality. Despite the damaging impact of hypertension
      and the availability of well-defined therapies and widely accepted target values for BP,
      interventions to improve BP control have had limited success.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed

      Description Background:

      There are 65 million Americans and over 8.5 million veterans who have been diagnosed with
      hypertension; yet only 31% of all hypertensive patients have their blood pressure (BP) under
      effective control (&lt;140/90 mm/Hg). Uncontrolled hypertension greatly increases the risk of
      cerebral vascular accidents, coronary artery disease, myocardial infarction, renal failure,
      congestive heart failure, and mortality. Despite the damaging impact of hypertension and the
      availability of well-defined therapies and widely accepted target values for BP,
      interventions to improve BP control have had limited success.

      Objectives:

      The study is one of the first to compare three interventions designed to improve BP control:
      a behavioral educational intervention, an evidence-based medication management intervention,
      and combined intervention for patients with poor BP control defined by home BP monitoring.
      The primary hypotheses are: 1) Patients who receive only the behavioral intervention will
      show improved rates of BP control as compared to the control group over 18 months of
      follow-up; 2) Patients who receive only the hypertension medication management intervention
      will show improved rates of BP control as compared to the control group over 18 months of
      follow-up; and, 3) Patients who receive the combined intervention will show higher rates of
      BP control as compared to all other patients over the 18 months of follow-up.

      Methods:

      A three-year randomized controlled trial among veterans with poor BP control testing three
      interventions in three VA primary care clinics is proposed to improve BP control. We will
      test these interventions using home BP monitoring in a four group design administered via the
      telephone: 1) control group - a group of hypertensive patients who receive usual care; 2)
      Nurse-administered tailored behavioral intervention previously tested (HSR&amp;D grant IIR
      20-034); 3) Nurse-administered medication management according to a hypertension decision
      support system that uses the VA's Computerized Medical Record System (VA HSR&amp;D grant CPI
      99275); 4) combination of the tailored behavioral and medication management interventions.

      A random sample of hypertensive patients with poor BP control at baseline were consented and
      randomly allocated to one of four arms. The interventions will activate only when home BP
      monitoring indicates inadequate BP control. Patients assigned to the behavioral intervention
      will receive a tailored self-management intervention to promote adherence with medication,
      information on the risks of hypertension and health behaviors at periodic telephone contacts.
      Patients will receive feedback about their recent BP values, continuous patient education,
      and will be monitored and supported to enhance treatment adherence. Patients randomized to
      the medication management arm will have their hypertension regimen changed by a nurse using a
      hypertension decision support system developed and validated in the VA. Medication
      recommendations generated are based on JNC 7 and the VA's hypertension treatment guidelines
      and are also individualized to patients' comorbid illnesses, laboratory values, and other
      elements of patients' clinical status. Medication management will be based on home BP
      monitoring and delivered by telephone. The nurse is part of an extended primary care team and
      communicates changes to the patients' primary care providers via a study physician.

      The primary outcome will be a dichotomous measure representing whether or not the patient's
      BP is in control: &gt;140/90 mm/Hg (non-diabetic) and &gt;130/80 mm/Hg (diabetics). Measures will
      be made at six-month intervals over 18 months (4 total measurements). We will model the
      outcome measures and evaluate the interventions using a mixed effects model for dichotomous
      outcomes.

      Status:

      Primary study enrollment began May 5, 2006 and was completed November 2007. We randomized 591
      participants in the study. Baseline recruitment was completed in November 2007. Participants'
      completed the six month follow-up interviews in June 2008 and 12 month follow-up in December
      2008. 18 month follow-up was completed June 2009.

      Study was granted an extension to complete two goals: 1) investigate the sustainability of BP
      control after completion of intervention, and , 2) examine what aspects of the intervention
      worked or did not work using qualitative interviews.

      Background/Rationale:

      Despite the impact of hypertension and the availability of well-defined therapies and widely
      accepted target values for blood pressure (BP), interventions to improve BP control have had
      limited success.

      Objectives:

      The study is one of the first to compare three interventions designed to improve BP control:
      a behavioral educational intervention, an evidence-based medication management intervention,
      and combined intervention for patients with poor BP control defined by home BP monitoring. We
      received an 11 month extension to evaluate 3 key components of the study (sustainability of
      BP effects, qualitative evaluation of the intervention, evaluation of the supporting
      materials used to ensure literacy levels and cultural sensitivity.)

      Methods:

      A 4-arm randomized trial with 18-month follow-up. Patents were selected from primary care
      clinics at the Durham VA Medical Center. Of the eligible patients, 591 individuals were
      randomized to either usual care or one of three telephone-based intervention groups. The
      intervention phone calls were triggered based on home BP values transmitted via
      telemonitoring devices. Patients were instructed to take their BP three times a week and
      transmit to study team. Behavioral management involved promoting health behaviors. Medication
      management involved adjustment of hypertension medications by a study physician and nurse
      based on hypertension treatment guidelines. The primary outcome was changes in BP control
      measured at six-month intervals over 18 months. For the sustainability extension of the
      study, in additional to collection of BP values, we will use qualitative analysis to examine
      the audio interviews.

      Status:

      Sustainability phase recruitment began May 1, 2010 and ended on Aug 15, 2010. Analyses are
      continuing.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Estimated Percentage of Participants in Blood Pressure Control at Baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>When patients had multiple blood pressure readings during their baseline visit, means of their systolic and diastolic readings were used as the baseline blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated Percentage of Participants in Blood Pressure Control at 6 Months</measure>
    <time_frame>6month</time_frame>
    <description>When patients had multiple blood pressure readings during their 6 month visit, means of their systolic and diastolic readings were used as the 6 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated Percentage of Participants in Blood Pressure Control at 12 Months</measure>
    <time_frame>12 month</time_frame>
    <description>When patients had multiple blood pressure readings during their 12 month visit, means of their systolic and diastolic readings were used as the 12 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated Percentage of Participants in Blood Pressure Control at 18 Months</measure>
    <time_frame>18 month</time_frame>
    <description>When patients had multiple blood pressure readings during their 18 month visit, means of their systolic and diastolic readings were used as the 18 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure Averages Systolic &amp; Diastolic</measure>
    <time_frame>Baseline</time_frame>
    <description>Blood pressure measured at Baseline.
BP control estimates are marginalized probabilities with corresponding 95% confidence intervals derived from a logistic mixed effects regression model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure Averages Systolic &amp; Diastolic</measure>
    <time_frame>12-month</time_frame>
    <description>Blood pressure measured at 12 month.
BP control estimates are marginalized probabilities with corresponding 95% confidence intervals derived from a logistic mixed effects regression model.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">591</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group - a group of hypertensive patient who receive usual care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nurse Behavioral intervention with Home BP Telemonitoring Nurse-administered tailored behavior intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nurse Medication Management with Home BP Telemonitoring -- Nurse administer medication management according to hypertension decision support system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nurse Combined intervention with Home BP Telemonitoring - Combination of the nurse administered tailored behavioral &amp; medication management interventions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nurse Behavioral intervention with Home BP Telemonitoring</intervention_name>
    <description>Nurse-administered behavior intervention</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nurse Medication Management with Home BP Telemonitoring</intervention_name>
    <description>Nurse administer medication management according to hypertension decision support</description>
    <arm_group_label>Arm 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nurse Combined intervention with Home BP Telemonitoring</intervention_name>
    <description>Combination of the nurse administered tailored behavioral &amp; medication management</description>
    <arm_group_label>Arm 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of uncontrolled hypertension,

          -  prescribed a medication to lower blood pressure,

          -  have a regular primary care physician at Durham VA Medical Center, and

          -  be a veteran. For Sustainability portion the patient must have participated in an
             intervention arm of primary study.

        Exclusion Criteria:

          -  Hospitalized in past 3 months for stroke,

          -  heart attack,

          -  surgery for blocked arteries,

          -  diagnosed with metastatic cancer or treated with dialysis,

          -  have a diagnosis of dementia or a hearing impairment which prevents them from being
             able to hear/speak on the telephone, and

          -  creatinine serum lab which exceed 2.5.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hayden B. Bosworth, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Durham VA Medical Center, Durham, NC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Durham VA Medical Center, Durham, NC</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bosworth HB, Olsen MK, McCant F, Harrelson M, Gentry P, Rose C, Goldstein MK, Hoffman BB, Powers B, Oddone EZ. Hypertension Intervention Nurse Telemedicine Study (HINTS): testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control. Am Heart J. 2007 Jun;153(6):918-24.</citation>
    <PMID>17540191</PMID>
  </reference>
  <results_reference>
    <citation>Crowley MJ, Grubber JM, Olsen MK, Bosworth HB. Factors associated with non-adherence to three hypertension self-management behaviors: preliminary data for a new instrument. J Gen Intern Med. 2013 Jan;28(1):99-106. doi: 10.1007/s11606-012-2195-1. Epub 2012 Aug 28.</citation>
    <PMID>22926634</PMID>
  </results_reference>
  <results_reference>
    <citation>Jackson GL, Oddone EZ, Olsen MK, Powers BJ, Grubber JM, McCant F, Bosworth HB. Racial differences in the effect of a telephone-delivered hypertension disease management program. J Gen Intern Med. 2012 Dec;27(12):1682-9. doi: 10.1007/s11606-012-2138-x. Epub 2012 Aug 3.</citation>
    <PMID>22865016</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang V, Smith VA, Bosworth HB, Oddone EZ, Olsen MK, McCant F, Powers BJ, Van Houtven CH. Economic evaluation of telephone self-management interventions for blood pressure control. Am Heart J. 2012 Jun;163(6):980-6. doi: 10.1016/j.ahj.2012.03.016. Epub 2012 May 21.</citation>
    <PMID>22709750</PMID>
  </results_reference>
  <results_reference>
    <citation>Crowley MJ, Smith VA, Olsen MK, Danus S, Oddone EZ, Bosworth HB, Powers BJ. Treatment intensification in a hypertension telemanagement trial: clinical inertia or good clinical judgment? Hypertension. 2011 Oct;58(4):552-8. doi: 10.1161/HYPERTENSIONAHA.111.174367. Epub 2011 Aug 15.</citation>
    <PMID>21844490</PMID>
  </results_reference>
  <results_reference>
    <citation>Bosworth HB, Powers BJ, Olsen MK, McCant F, Grubber J, Smith V, Gentry PW, Rose C, Van Houtven C, Wang V, Goldstein MK, Oddone EZ. Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. Arch Intern Med. 2011 Jul 11;171(13):1173-80. doi: 10.1001/archinternmed.2011.276.</citation>
    <PMID>21747013</PMID>
  </results_reference>
  <results_reference>
    <citation>Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011 Jun 21;154(12):781-8, W-289-90. doi: 10.7326/0003-4819-154-12-201106210-00005.</citation>
    <PMID>21690592</PMID>
  </results_reference>
  <results_reference>
    <citation>Powers BJ, Danus S, Grubber JM, Olsen MK, Oddone EZ, Bosworth HB. The effectiveness of personalized coronary heart disease and stroke risk communication. Am Heart J. 2011 Apr;161(4):673-80. doi: 10.1016/j.ahj.2010.12.021.</citation>
    <PMID>21473965</PMID>
  </results_reference>
  <results_reference>
    <citation>Zullig LL, Melnyk SD, Goldstein K, Shaw RJ, Bosworth HB. The role of home blood pressure telemonitoring in managing hypertensive populations. Curr Hypertens Rep. 2013 Aug;15(4):346-55. doi: 10.1007/s11906-013-0351-6. Review.</citation>
    <PMID>23625207</PMID>
  </results_reference>
  <results_reference>
    <citation>Bowen ME, Bosworth HB, Roumie CL. Blood pressure control in a hypertension telemedicine intervention: does distance to primary care matter? J Clin Hypertens (Greenwich). 2013 Oct;15(10):723-30. doi: 10.1111/jch.12172. Epub 2013 Jul 23.</citation>
    <PMID>24088280</PMID>
  </results_reference>
  <results_reference>
    <citation>Bosworth HB, Olsen MK, Dudley T, Orr M, Goldstein MK, Datta SK, McCant F, Gentry P, Simel DL, Oddone EZ. Patient education and provider decision support to control blood pressure in primary care: a cluster randomized trial. Am Heart J. 2009 Mar;157(3):450-6. doi: 10.1016/j.ahj.2008.11.003. Epub 2009 Jan 10.</citation>
    <PMID>19249414</PMID>
  </results_reference>
  <results_reference>
    <citation>McCant F, McKoy G, Grubber J, Olsen MK, Oddone E, Powers B, Bosworth HB. Feasibility of blood pressure telemonitoring in patients with poor blood pressure control. J Telemed Telecare. 2009;15(6):281-5. doi: 10.1258/jtt.2009.090202.</citation>
    <PMID>19720764</PMID>
  </results_reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2005</study_first_submitted>
  <study_first_submitted_qc>October 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2005</study_first_posted>
  <results_first_submitted>August 29, 2014</results_first_submitted>
  <results_first_submitted_qc>November 21, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 1, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Telemedicine</keyword>
  <keyword>Adherence</keyword>
  <keyword>Tailored Nurse Intervention</keyword>
  <keyword>Home Blood Pressure Monitoring</keyword>
  <keyword>cardiovascular disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1- Control</title>
          <description>A group of hypertensive patients who receive usual care</description>
        </group>
        <group group_id="P2">
          <title>Arm 2 - Nurse Behavioral Int</title>
          <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
        </group>
        <group group_id="P3">
          <title>Arm 3 - Nurse Med Managment Int</title>
          <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
        </group>
        <group group_id="P4">
          <title>Arm 4 - Combined Behavioral and Med Mgmt Int</title>
          <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="147"/>
                <participants group_id="P2" count="148"/>
                <participants group_id="P3" count="149"/>
                <participants group_id="P4" count="147"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>6 Month f/u</title>
              <participants_list>
                <participants group_id="P1" count="132"/>
                <participants group_id="P2" count="134"/>
                <participants group_id="P3" count="135"/>
                <participants group_id="P4" count="134"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>12 Month f/u</title>
              <participants_list>
                <participants group_id="P1" count="137"/>
                <participants group_id="P2" count="127"/>
                <participants group_id="P3" count="132"/>
                <participants group_id="P4" count="127"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>18 Month f/u</title>
              <participants_list>
                <participants group_id="P1" count="124"/>
                <participants group_id="P2" count="131"/>
                <participants group_id="P3" count="126"/>
                <participants group_id="P4" count="122"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="129"/>
                <participants group_id="P2" count="134"/>
                <participants group_id="P3" count="127"/>
                <participants group_id="P4" count="128"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="22"/>
                <participants group_id="P4" count="19"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Excluded - did not meet criteria</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All data except blood pressure, age, gender were patient-reported.</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1- Control</title>
          <description>A group of hypertensive patients who receive usual care</description>
        </group>
        <group group_id="B2">
          <title>Arm 2 - Nurse Behavioral Int</title>
          <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
        </group>
        <group group_id="B3">
          <title>Arm 3 - Nurse Med Managment Int</title>
          <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
        </group>
        <group group_id="B4">
          <title>Arm 4 - Combined Behavioral and Med Mgmt Int</title>
          <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="147"/>
            <count group_id="B2" value="148"/>
            <count group_id="B3" value="149"/>
            <count group_id="B4" value="147"/>
            <count group_id="B5" value="591"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" spread="10"/>
                    <measurement group_id="B2" value="63" spread="11"/>
                    <measurement group_id="B3" value="64" spread="10"/>
                    <measurement group_id="B4" value="63" spread="11"/>
                    <measurement group_id="B5" value="64" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="141"/>
                    <measurement group_id="B2" value="136"/>
                    <measurement group_id="B3" value="139"/>
                    <measurement group_id="B4" value="126"/>
                    <measurement group_id="B5" value="542"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="73"/>
                    <measurement group_id="B4" value="64"/>
                    <measurement group_id="B5" value="289"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="72"/>
                    <measurement group_id="B4" value="76"/>
                    <measurement group_id="B5" value="285"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="147"/>
                    <measurement group_id="B2" value="148"/>
                    <measurement group_id="B3" value="149"/>
                    <measurement group_id="B4" value="147"/>
                    <measurement group_id="B5" value="591"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Estimated Percentage of Participants in Blood Pressure Control at Baseline</title>
        <description>When patients had multiple blood pressure readings during their baseline visit, means of their systolic and diastolic readings were used as the baseline blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1- Control</title>
            <description>a group of hypertensive patients who receive usual care</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Nurse Behavioral Int</title>
            <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - Nurse Med Management Int</title>
            <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Combined Behaviorial and Med Mgmt Int</title>
            <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Percentage of Participants in Blood Pressure Control at Baseline</title>
          <description>When patients had multiple blood pressure readings during their baseline visit, means of their systolic and diastolic readings were used as the baseline blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
          <units>% of particpants w/ controlled BP</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="147"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="149"/>
                <count group_id="O4" value="147"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="53"/>
                    <measurement group_id="O4" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled Systolic BP at Baseline</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>59.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>55.7</ci_lower_limit>
            <ci_upper_limit>63.9</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled Systolic BP at Baseline</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of patients with controled SBP</param_type>
            <param_value>59.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>55.7</ci_lower_limit>
            <ci_upper_limit>64.0</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled BP at Baseline</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of patinets with controlled SBP</param_type>
            <param_value>59.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>55.6</ci_lower_limit>
            <ci_upper_limit>63.9</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled Systolic BP at Baseline</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>59.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>55.6</ci_lower_limit>
            <ci_upper_limit>63.9</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Estimated Percentage of Participants in Blood Pressure Control at 6 Months</title>
        <description>When patients had multiple blood pressure readings during their 6 month visit, means of their systolic and diastolic readings were used as the 6 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
        <time_frame>6month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1- Control</title>
            <description>a group of hypertensive patients who receive usual care</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Nurse Behavioral Int</title>
            <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - Nurse Med Management Int</title>
            <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Combined Behaviorial and Med Mgmt Int</title>
            <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Percentage of Participants in Blood Pressure Control at 6 Months</title>
          <description>When patients had multiple blood pressure readings during their 6 month visit, means of their systolic and diastolic readings were used as the 6 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
          <units>% of particpants with controlled SBP</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="132"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="135"/>
                <count group_id="O4" value="134"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="61"/>
                    <measurement group_id="O3" value="65"/>
                    <measurement group_id="O4" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled Systolic BP at 6 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>58.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>49.3</ci_lower_limit>
            <ci_upper_limit>66.7</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled systolic BP at 6 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>60.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>52.5</ci_lower_limit>
            <ci_upper_limit>69.3</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled systolic BP at 6 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>65.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>56.9</ci_lower_limit>
            <ci_upper_limit>73.1</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled systolic BP at 6 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>63.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>55.6</ci_lower_limit>
            <ci_upper_limit>72.0</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 2 - Nurse Behavioral and Arm 1 - Control at 6months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% diff</param_type>
            <param_value>2.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.0</ci_lower_limit>
            <ci_upper_limit>14.9</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 2 - Nurse Med Management and Arm 1 - Control at 6months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% Diff</param_type>
            <param_value>6.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.7</ci_lower_limit>
            <ci_upper_limit>18.7</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 2 - Combined Behavioral &amp; Med Mgmt and Arm 1 - Control at 6months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% Diff</param_type>
            <param_value>5.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.0</ci_lower_limit>
            <ci_upper_limit>17.6</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Estimated Percentage of Participants in Blood Pressure Control at 12 Months</title>
        <description>When patients had multiple blood pressure readings during their 12 month visit, means of their systolic and diastolic readings were used as the 12 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
        <time_frame>12 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1- Control</title>
            <description>a group of hypertensive patients who receive usual care</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Nurse Behavioral Int</title>
            <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - Nurse Med Management Int</title>
            <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Combined Behaviorial and Med Mgmt Int</title>
            <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Percentage of Participants in Blood Pressure Control at 12 Months</title>
          <description>When patients had multiple blood pressure readings during their 12 month visit, means of their systolic and diastolic readings were used as the 12 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
          <units>% of particpants with controlled SBP</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="137"/>
                <count group_id="O2" value="127"/>
                <count group_id="O3" value="132"/>
                <count group_id="O4" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                    <measurement group_id="O2" value="73"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled systolic BP at 12 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>59.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>51.4</ci_lower_limit>
            <ci_upper_limit>68.3</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled systolic BP at 12 months</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>73.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>65.6</ci_lower_limit>
            <ci_upper_limit>80.7</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled systolic BP at 12 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>73.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>66.1</ci_lower_limit>
            <ci_upper_limit>80.7</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled Systolic BP at 12 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>68.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>60.5</ci_lower_limit>
            <ci_upper_limit>76.6</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 2 - Nurse Behavioral and Arm 1 - Control at 12 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% Diff</param_type>
            <param_value>13.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.0</ci_lower_limit>
            <ci_upper_limit>24.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 3 - Nurse Med Management and Arm 1 - Control at 12 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% Diff</param_type>
            <param_value>13.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.4</ci_lower_limit>
            <ci_upper_limit>24.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 4 - Combined Behavioral &amp; Med Mgmt and Arm 1 - Control at 12 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% diff</param_type>
            <param_value>8.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.9</ci_lower_limit>
            <ci_upper_limit>20.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Estimated Percentage of Participants in Blood Pressure Control at 18 Months</title>
        <description>When patients had multiple blood pressure readings during their 18 month visit, means of their systolic and diastolic readings were used as the 18 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
        <time_frame>18 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1- Control</title>
            <description>a group of hypertensive patients who receive usual care</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Nurse Behavioral Int</title>
            <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - Nurse Med Management Int</title>
            <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Combined Behaviorial and Med Mgmt Int</title>
            <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Percentage of Participants in Blood Pressure Control at 18 Months</title>
          <description>When patients had multiple blood pressure readings during their 18 month visit, means of their systolic and diastolic readings were used as the 18 month blood pressure values; Using Joint National Committee 7 Report (JNC7) blood pressure guidelines for BP control: &lt;140/90mmHg for non-diabetic patients and &lt; 130/80mmHg for diabetic patients</description>
          <units>% of particpants with controlled SBP</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="124"/>
                <count group_id="O2" value="131"/>
                <count group_id="O3" value="126"/>
                <count group_id="O4" value="122"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="64"/>
                    <measurement group_id="O4" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled Systolic BP at 18 months</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>61.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>53.0</ci_lower_limit>
            <ci_upper_limit>70.6</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled BP at 18 months</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>59.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>50.8</ci_lower_limit>
            <ci_upper_limit>67.9</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled systolic BP at 18 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>63.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>55.1</ci_lower_limit>
            <ci_upper_limit>72.0</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated % of participants with controlled systolic BP at 18 months</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % of Patients with controlled SBP</param_type>
            <param_value>71.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>63.7</ci_lower_limit>
            <ci_upper_limit>79.5</ci_upper_limit>
            <estimate_desc>Joint National Committee 7 blood pressure control: &lt; 140/90 mmHg for non-diabetics; &lt;130/80 mmHg for diabetics</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 2 - Nurse Behavioral and Arm 1 - Control at 18 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% Diff</param_type>
            <param_value>-2.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-14.6</ci_lower_limit>
            <ci_upper_limit>9.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 3 - Nurse Med Management and Arm 1 - Control at 18 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% Diff</param_type>
            <param_value>1.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10.3</ci_lower_limit>
            <ci_upper_limit>13.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated Difference in Percentage of Patients with Controlled Systolic Blood pressure between Intervention Arm 4 - Combined Behavioral &amp; Med Mgmt and Arm 1 - Control at 18 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>% Diff</param_type>
            <param_value>9.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.9</ci_lower_limit>
            <ci_upper_limit>21.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Blood Pressure Averages Systolic &amp; Diastolic</title>
        <description>Blood pressure measured at Baseline.
BP control estimates are marginalized probabilities with corresponding 95% confidence intervals derived from a logistic mixed effects regression model.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1- Control</title>
            <description>a group of hypertensive patients who receive usual care</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Nurse Behavioral Int</title>
            <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - Nurse Med Management Int</title>
            <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Combined Behaviorial and Med Mgmt Int</title>
            <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure Averages Systolic &amp; Diastolic</title>
          <description>Blood pressure measured at Baseline.
BP control estimates are marginalized probabilities with corresponding 95% confidence intervals derived from a logistic mixed effects regression model.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="147"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="149"/>
                <count group_id="O4" value="147"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic BP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128" spread="17"/>
                    <measurement group_id="O2" value="129" spread="19"/>
                    <measurement group_id="O3" value="132" spread="21"/>
                    <measurement group_id="O4" value="127" spread="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic BP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78" spread="14"/>
                    <measurement group_id="O2" value="77" spread="12"/>
                    <measurement group_id="O3" value="78" spread="14"/>
                    <measurement group_id="O4" value="77" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Blood Pressure Averages Systolic &amp; Diastolic</title>
        <description>Blood pressure measured at 12 month.
BP control estimates are marginalized probabilities with corresponding 95% confidence intervals derived from a logistic mixed effects regression model.</description>
        <time_frame>12-month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1- Control</title>
            <description>a group of hypertensive patients who receive usual care</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 - Nurse Behavioral Int</title>
            <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 - Nurse Med Management Int</title>
            <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
          </group>
          <group group_id="O4">
            <title>Arm 4 - Combined Behaviorial and Med Mgmt Int</title>
            <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure Averages Systolic &amp; Diastolic</title>
          <description>Blood pressure measured at 12 month.
BP control estimates are marginalized probabilities with corresponding 95% confidence intervals derived from a logistic mixed effects regression model.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="137"/>
                <count group_id="O2" value="127"/>
                <count group_id="O3" value="132"/>
                <count group_id="O4" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic BP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127.1" spread="1.5"/>
                    <measurement group_id="O2" value="125.0" spread="1.5"/>
                    <measurement group_id="O3" value="124.7" spread="1.5"/>
                    <measurement group_id="O4" value="122.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic BP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.6" spread=".9"/>
                    <measurement group_id="O2" value="74.9" spread=".9"/>
                    <measurement group_id="O3" value="74.6" spread=".9"/>
                    <measurement group_id="O4" value="75.6" spread=".9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated differences in systolic blood pressure at 12months between Arm 1 - Control and Arm 2 - Nurse Behavioral</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % Diff in Patient w/Controlled SBP</param_type>
            <param_value>2.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.1</ci_lower_limit>
            <ci_upper_limit>7.1</ci_upper_limit>
            <estimate_desc>Systolic blood pressure estimates are based on the longitudinal data model with an unstructured covariance matrix. Negative differences reflect improvement compared to usual care, and positive differences reflect worsening compared to usual care.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Estimated differences in diastolic blood pressure at 12months between Arm 1 - Control and Arm 2 - Nurse Behavioral</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. Dif in Patient w/Controlled DBP</param_type>
            <param_value>.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.7</ci_lower_limit>
            <ci_upper_limit>3.8</ci_upper_limit>
            <estimate_desc>Diastolic blood pressure estimates are based on the longitudinal data model with an unstructured covariance matrix. Negative differences reflect improvement compared to usual care, and positive differences reflect worsening compared to usual care.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated differences in systolic blood pressure at 12months between Arm 1 - Control and Arm 3 - Nurse Med Management.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % Diff in Patient w/Controlled SBP</param_type>
            <param_value>0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.8</ci_lower_limit>
            <ci_upper_limit>5.5</ci_upper_limit>
            <estimate_desc>Systolic blood pressure estimates are based on the longitudinal data model with an unstructured covariance matrix. Negative differences reflect improvement compared to usual care, and positive differences reflect worsening compared to usual care.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Estimated differences in diastolic blood pressure at 12months between Arm 1 - Control and Arm 3 - Nuse Med Management</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % Diff in Patient w/Controlled DBP</param_type>
            <param_value>0.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.6</ci_lower_limit>
            <ci_upper_limit>4.0</ci_upper_limit>
            <estimate_desc>Diastolic blood pressure estimates are based on the longitudinal data model with an unstructured covariance matrix. Negative differences reflect improvement compared to usual care, and positive differences reflect worsening compared to usual care.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated differences in systolic blood pressure at 12months between Arm 1 - Control and Arm 4 - Combined Behaviorial and Med Management</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % Diff in Patient w/Controlled SBP</param_type>
            <param_value>1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.3</ci_lower_limit>
            <ci_upper_limit>6.6</ci_upper_limit>
            <estimate_desc>Systolic blood pressure estimates are based on the longitudinal data model with an unstructured covariance matrix. Negative differences reflect improvement compared to usual care, and positive differences reflect worsening compared to usual care.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Estimated differences in diastolic blood pressure at 12months between Arm 1 - Control and Arm 4 - Combined Behaviorial and Med Management</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Est. % Diff in Patient w/Controlled DBP</param_type>
            <param_value>3.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.3</ci_lower_limit>
            <ci_upper_limit>6.6</ci_upper_limit>
            <estimate_desc>Diastolic blood pressure estimates are based on the longitudinal data model with an unstructured covariance matrix. Negative differences reflect improvement compared to usual care, and positive differences reflect worsening compared to usual care.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Overall length of study</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm 1- Control</title>
          <description>A group of hypertensive patients who receive usual care</description>
        </group>
        <group group_id="E2">
          <title>Arm 2 - Nurse Behavioral Int</title>
          <description>Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention</description>
        </group>
        <group group_id="E3">
          <title>Arm 3 - Nurse Med Managment Int</title>
          <description>Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support</description>
        </group>
        <group group_id="E4">
          <title>Arm 4 - Combined Behavioral and Med Mgmt Int</title>
          <description>Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral &amp; medication management</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="147"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="148"/>
                <counts group_id="E3" subjects_affected="68" subjects_at_risk="149"/>
                <counts group_id="E4" subjects_affected="60" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>w/recurrent nosebleed</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Circulatory</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="147"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="148"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="149"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Coronary</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="147"/>
                <counts group_id="E2" events="21" subjects_affected="18" subjects_at_risk="148"/>
                <counts group_id="E3" events="26" subjects_affected="20" subjects_at_risk="149"/>
                <counts group_id="E4" events="18" subjects_affected="11" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Coronary - Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="147"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Coronary Safety Protocol</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="147"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="149"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="149"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="147"/>
                <counts group_id="E2" events="18" subjects_affected="11" subjects_at_risk="148"/>
                <counts group_id="E3" events="15" subjects_affected="7" subjects_at_risk="149"/>
                <counts group_id="E4" events="7" subjects_affected="7" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="148"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Optometry</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="147"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastro-Intestinal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="147"/>
                <counts group_id="E2" events="30" subjects_affected="15" subjects_at_risk="148"/>
                <counts group_id="E3" events="17" subjects_affected="11" subjects_at_risk="149"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>General - ER visits</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="147"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="148"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="149"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>General - Med-Refill</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="147"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>General - Med Side Effect</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="147"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="149"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infections</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="147"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="148"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="149"/>
                <counts group_id="E4" events="17" subjects_affected="9" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="147"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="148"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="149"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Orthopedic Issues</sub_title>
                <counts group_id="E1" events="17" subjects_affected="11" subjects_at_risk="147"/>
                <counts group_id="E2" events="22" subjects_affected="15" subjects_at_risk="148"/>
                <counts group_id="E3" events="26" subjects_affected="18" subjects_at_risk="149"/>
                <counts group_id="E4" events="30" subjects_affected="21" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer Tx</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurologic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="147"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="148"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="149"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychological</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="147"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="148"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="149"/>
                <counts group_id="E4" events="5" subjects_affected="3" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="148"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Urology</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="147"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="149"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="147"/>
                <counts group_id="E2" events="21" subjects_affected="17" subjects_at_risk="148"/>
                <counts group_id="E3" events="20" subjects_affected="13" subjects_at_risk="149"/>
                <counts group_id="E4" events="10" subjects_affected="9" subjects_at_risk="147"/>
              </event>
              <event>
                <sub_title>Pulmonary-Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatologic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="147"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="148"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="149"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="147"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="148"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="147"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="148"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="149"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="147"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hayden B. Bosworth, PhD</name_or_title>
      <organization>Center for Primary Care, HSRD COIN</organization>
      <phone>919-286-0411 ext 7107</phone>
      <email>hayden.bosworth@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

